Exlites Holdings International Inc. (OTC PINK: EXHI), a healthcare company focused on medical and consumer health products, today announced it has signed a letter of intent (LOI) to acquire a medical company Devon Orthopedic Implants LLC. (DOI) with proprietary patented medical products. The acquisition would see EXHI absorb DOI.
“As we emerge from COVID, we are excited and optimistic for this acquisition and for the future of EXHI. We seek to expand our product breadth and distribution into the medical field. DOI gives us a solid base that we can combine and accelerate our objective which is to be a dominant player serving the medical community with innovative products that improve patients lives.” Stated Mark Julian, President of EXHI.
“We are moving quickly to complete the acquisition agreement within the next 60 days, which would enable us to launch some products in an expanded distribution in the third quarter of 2021. There are many synergies between our two companies, and we are looking forward to a successful mutual path moving forward.”
Additionally, EXHI has filed all necessary disclosures and paperwork with the OTC Markets and is awaiting final clearance to be current on the OTC Markets. The filings include calendar years Jan 31, 2020 and Jan 31, 2021 and 1st qtr April 30, 2021.
To learn more about EXHI please visit the Exlites Holdings International Inc website at www.exlitesholdings.us
About Exlites Holdings International Inc. (www.exlitesholdings.us)
Exlites Holdings International Inc. (OTC PINK: EXHI) EXHI is a publicly traded company listed on the OTC markets. The company’s objective is to expand its client base for both medical and consumer products, to generate a growing market and expand our current product offerings. The company has experience in several facets from manufacturing, marketing, distribution and relationships. Within the medical space the company has proprietary, patented and patent pending products, utilizing distribution which they are in the process of maximizing. The company manufactures, distributes and bills medical products. The company has extensive experience in mergers and acquisitions, innovation and creativity, joint ventures, consumer health care goods and growing and scaling companies for profits and divestiture.